BT Brands (BTBD) news
Recent news
First Tracks Biotherapeutics shares rise 13.3% premarket after positive results from celiac disease drug trial
First Tracks Biotherapeutics Inc. (NASDAQ: FTBT) reported a 13.3% increase in premarket trading on October 12, 2026, following the release of positive clinical trial results . The company announced that the drug demonstrated a favorable safety profile and showed measurable efficacy in reducing…
AInvest Wire · 3d agoUK CMA invitation to comment on BT/TalkTalk deal closes Oct 9
The UK Competition and Markets Authority (CMA) has announced that the deadline for public and stakeholder comments on the proposed merger between BT and TalkTalk is set for [October 9, 2026][1]. The CMA is conducting a Phase 1 review to assess whether the deal could substantially reduce competition…
AInvest Wire · Oct 5, 2026BT: Pending regulatory review, TalkTalk and BT will operate separately and continue to compete
BT and TalkTalk will continue to operate as separate entities and remain competitors in the UK broadband market, following a regulatory review and recent developments in the sector. The Competition and Markets Authority (CMA) has published its determination regarding superfast broadband,…
AInvest Wire · Oct 5, 2026BT sees FY normalized FCF GBP 2.0B, saw GBP 2.0B
BT Group (LON:BTA) reported normalized free cash flow (FCF) of GBP 2.0 billion for the fiscal year ending 31 March 2026, meeting its target for the period . This achievement marks a key milestone in the company’s multi-year restructuring plan, which has focused on cost reductions, operational…
AInvest Wire · Oct 5, 2026BT - Martijn Blanken appointed CEO of BT International and CEO-designate of joint venture with Verizon
BT Group and Verizon have announced the formation of a joint venture combining their international enterprise operations, with Martijn Blanken appointed as CEO-designate of the new entity , pending regulatory approval and completion of the transaction. The joint venture, expected to finalize in…
AInvest Wire · Oct 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.